Jane Street’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-500,561
| Closed | -$10.8M | – | 11544 |
|
|
2025
Q4 | $10.8M | Sell |
500,561
-59,015
| -11% | -$1.15M | ﹤0.01% | 2240 |
|
|
2025
Q3 | $8.54M | Buy |
559,576
+475,057
| +562% | +$6.18M | ﹤0.01% | 2621 |
|
|
2025
Q2 | $748K | Buy |
+84,519
| New | +$743K | ﹤0.01% | 6163 |
|
|
2025
Q1 | – | Sell |
-100,118
| Closed | -$1.05M | – | 9397 |
|
|
2024
Q4 | $1.05M | Buy |
100,118
+1,561
| +2% | +$19K | ﹤0.01% | 5287 |
|
|
2024
Q3 | $1.29M | Buy |
98,557
+30,039
| +44% | +$458K | ﹤0.01% | 5357 |
|
|
2024
Q2 | $963K | Buy |
68,518
+11,913
| +21% | +$194K | ﹤0.01% | 5846 |
|
|
2024
Q1 | $956K | Sell |
56,605
-53,300
| -48% | -$794K | ﹤0.01% | 5504 |
|
|
2023
Q4 | $1.55M | Buy |
109,905
+88,225
| +407% | +$1.04M | ﹤0.01% | 4771 |
|
|
2023
Q3 | $223K | Sell |
21,680
-236,370
| -92% | -$3.17M | ﹤0.01% | 7479 |
|
|
2023
Q2 | $4.25M | Buy |
258,050
+232,151
| +896% | +$3.02M | ﹤0.01% | 2968 |
|
|
2023
Q1 | $237K | Sell |
25,899
-49,000
| -65% | -$403K | ﹤0.01% | 7569 |
|
|
2022
Q4 | $536K | Buy |
+74,899
| New | +$525K | ﹤0.01% | 6007 |
|
|
2022
Q3 | – | Sell |
-33,220
| Closed | -$81K | – | 9665 |
|
|
2022
Q2 | $81K | Buy |
33,220
+4,816
| +17% | +$19.8K | ﹤0.01% | 8750 |
|
|
2022
Q1 | $194K | Sell |
28,404
-52,265
| -65% | -$359K | ﹤0.01% | 9050 |
|
|
2021
Q4 | $652K | Buy |
+80,669
| New | +$737K | ﹤0.01% | 6766 |
|
|
2021
Q3 | – | Sell |
-17,397
| Closed | -$137K | – | 9897 |
|
|
2021
Q2 | $117K | Sell |
17,397
-61,808
| -78% | -$491K | ﹤0.01% | 9194 |
|
|
2021
Q1 | $716K | Buy |
79,205
+61,660
| +351% | +$499K | ﹤0.01% | 6126 |
|
|
2020
Q4 | $117K | Buy |
+17,545
| New | +$110K | ﹤0.01% | 7159 |
|
|
2019
Q4 | – | Sell |
-13,819
| Closed | -$57K | – | 5030 |
|
|
2019
Q3 | $57K | Buy |
+13,819
| New | +$34.6K | ﹤0.01% | 4863 |
|
|
2014
Q3 | – | Sell |
-18,523
| Closed | -$278K | – | 2521 |
|
|
2014
Q2 | $278K | Buy |
+18,523
| New | +$223K | ﹤0.01% | 1902 |
|
Other funds holding AVDL
Jane Street's AVDL Position: Q1 2026 in Review
Jane Street sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 500,561 shares — an estimated $10.8M sold.
Jane Street first reported a position in AVDL in Q2 2014 and held it in 20 quarters. The position peaked at $10.8M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.
- Jane Street reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Jane Street sold 500,561 Avadel Pharmaceuticals shares in Q1 2026, an estimated $10.8M.
- Jane Street first reported a position in Avadel Pharmaceuticals in Q2 2014 and held it in 20 quarters.
- Jane Street's Avadel Pharmaceuticals position peaked at $10.8M in Q4 2025.
- 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.